These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37553962)

  • 1. Regulation of cholesterol homeostasis in osteoporosis mechanisms and therapeutics.
    Bao C; Wu T; Zhu S; Wang X; Zhang Y; Wang X; Yang L; He C
    Clin Sci (Lond); 2023 Aug; 137(15):1131-1143. PubMed ID: 37553962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Function of Cholesterol Oxidation Products Involved in Osteoporosis Pathogenesis.
    Che Y; Yang J; Tang F; Wei Z; Chao Y; Li N; Li H; Wu S; Dong X
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian target of rapamycin as a therapeutic target in osteoporosis.
    Shen G; Ren H; Qiu T; Zhang Z; Zhao W; Yu X; Huang J; Tang J; Liang D; Yao Z; Yang Z; Jiang X
    J Cell Physiol; 2018 May; 233(5):3929-3944. PubMed ID: 28834576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mechanism of Bone Remodeling After Bone Aging.
    Fang H; Deng Z; Liu J; Chen S; Deng Z; Li W
    Clin Interv Aging; 2022; 17():405-415. PubMed ID: 35411139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Rhein Derivative Modulates Bone Formation and Resorption and Ameliorates Estrogen-Dependent Bone Loss.
    Jiang M; Wang T; Yan X; Liu Z; Yan Y; Yang K; Qi J; Zhou H; Qian N; Zhou Q; Chen B; Xu X; Xi X; Yang C; Deng L
    J Bone Miner Res; 2019 Feb; 34(2):361-374. PubMed ID: 30320929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins.
    Loukas AT; Papadourakis M; Panagiotopoulos V; Zarmpala A; Chontzopoulou E; Christodoulou S; Katsila T; Zoumpoulakis P; Matsoukas MT
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine Kinase Src Is a Regulatory Factor of Bone Homeostasis.
    Matsubara T; Yasuda K; Mizuta K; Kawaue H; Kokabu S
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoblast-n-Osteoclast: Making Headway to Osteoporosis Treatment.
    Kaur M; Nagpal M; Singh M
    Curr Drug Targets; 2020; 21(16):1640-1651. PubMed ID: 32735518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Communication factors-promising targets in osteoporosis treatment.
    Zhang Y; Liu P; Li J; Li K; Teng Y; Wang X; Li X
    Curr Drug Targets; 2014 Feb; 15(2):156-63. PubMed ID: 23919828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD39 Produced from Human GMSCs Regulates the Balance of Osteoclasts and Osteoblasts through the Wnt/β-Catenin Pathway in Osteoporosis.
    Wu W; Xiao Z; Chen Y; Deng Y; Zeng D; Liu Y; Huang F; Wang J; Liu Y; Bellanti JA; Rong L; Zheng SG
    Mol Ther; 2020 Jun; 28(6):1518-1532. PubMed ID: 32304668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone, its fragments and their analogs for the treatment of osteoporosis.
    Whitfield JF; Morley P; Willick GE
    Treat Endocrinol; 2002; 1(3):175-90. PubMed ID: 15799210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of miRNAs, lncRNAs and circRNAs on osteoporosis as regulatory factors of bone homeostasis (Review).
    Li Z; Xue H; Tan G; Xu Z
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblast as a target of anti-osteoporotic treatment.
    Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP
    Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ying and Yang of Sphingosine-1-Phosphate Signalling within the Bone.
    Frost K; Naylor AJ; McGettrick HM
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities.
    Aggarwal R; Lu J; Kanji S; Joseph M; Das M; Noble GJ; McMichael BK; Agarwal S; Hart RT; Sun Z; Lee BS; Rosol TJ; Jackson R; Mao HQ; Pompili VJ; Das H
    PLoS One; 2012; 7(6):e39365. PubMed ID: 22724005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of bone health through physical exercise: Mechanisms and types.
    Chang X; Xu S; Zhang H
    Front Endocrinol (Lausanne); 2022; 13():1029475. PubMed ID: 36568096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates and connexin 43: a critical review of evidence.
    Sadr-Eshkevari P; Ashnagar S; Rashad A; Dietz M; Jackowski J; Abdulazim A; Prochnow N
    Cell Commun Adhes; 2014 Oct; 21(5):241-7. PubMed ID: 24946183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Energy Metabolism of Bone.
    Motyl KJ; Guntur AR; Carvalho AL; Rosen CJ
    Toxicol Pathol; 2017 Oct; 45(7):887-893. PubMed ID: 29096593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteoporosis from the point of view of the clinical endocrinologist.
    Szũcs J
    Agents Actions; 1994 Mar; 41(1-2):80-3. PubMed ID: 8079825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutic targets for osteoporosis.
    Gennari L; Merlotti D; Falchetti A; Eller Vainicher C; Cosso R; Chiodini I
    Expert Opin Ther Targets; 2020 Feb; 24(2):115-130. PubMed ID: 32050822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.